CCR2 and neoplasm: Using these definitions and the gating strategy outlined in Figure S5, we found that MDSCs expressed significantly more CCR2 than tumor-associated CD4 or CD8 T cells, TAN, TAM or tumor cells (Figure 1A,B), whereas the tumor cells themselves expressed the highest levels of MCP-1 (Figure 1C,D).